Haznedaroglu, I. “MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)”. Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6, no. 1, Dec. 2013, p. e2014009, doi:10.4084/mjhid.2014.009.